Cargando…
Multipurpose Drugs Active Against Both Plasmodium spp. and Microorganisms: Potential Application for New Drug Development
Malaria, a disease caused by the protozoan parasites Plasmodium spp., is still causing serious problems in endemic regions in the world. Although the WHO recommends artemisinin combination therapies for the treatment of malaria patients, the emergence of artemisinin-resistant parasites has become a...
Autores principales: | Endo, Takuro, Takemae, Hitoshi, Sharma, Indu, Furuya, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740689/ https://www.ncbi.nlm.nih.gov/pubmed/35004357 http://dx.doi.org/10.3389/fcimb.2021.797509 |
Ejemplares similares
-
Ten-Year Molecular Surveillance of Drug-Resistant Plasmodium spp. Isolated From the China–Myanmar Border
por: Tang, Tongke, et al.
Publicado: (2021) -
A review of malaria molecular markers for drug resistance in Plasmodium falciparum and Plasmodium vivax in China
por: Wang, Siqi, et al.
Publicado: (2023) -
Unraveling the impact of Lactobacillus spp. and other urinary microorganisms on the efficacy of mirabegron in female patients with overactive bladder
por: Zhou, Zhipeng, et al.
Publicado: (2022) -
Genomic Epidemiology of Antimalarial Drug Resistance in Plasmodium falciparum in Southern China
por: Huang, Fang, et al.
Publicado: (2021) -
Evaluation of the Effect of Gene Duplication by Genome Editing on Drug Resistance in Plasmodium falciparum
por: Kubota, Rie, et al.
Publicado: (2022)